Glucagon-Like Peptide-1 Receptor Agonist Eligibility Among US Adolescents and Young Adults

This cross-sectional study describes demographic, clinical, and socioeconomic characteristics of US adolescents and young adults who are eligible to receive glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Corresponding Author: Ashwin K. Chetty, BS, Yale School of Medicine, 333 Cedar St, New Haven, CT 06510 (ashwin.chetty@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.